In melanoma cells the low or absent levels of miR-126&126*, unblocking ADAM9 and MMP7, should result in an increased activation of pro-HB-EGF, consequently producing a higher quantity of HB-EGF-C translocation into the nucleus [26]. The gene discussed is ADAM9; the disease is melanoma.